Tourniquet-free pediatric trigger thumb release: Single-center experience and clinical outcomes
Acta Orthopaedica et Traumatologica Turcica, cilt.60, sa.6, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 60 Sayı: 6
- Basım Tarihi: 2026
- Doi Numarası: 10.5152/j.aott.2026.25830
- Dergi Adı: Acta Orthopaedica et Traumatologica Turcica
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Directory of Open Access Journals, Biomedical Reference Collection: Corporate Edition (EBSCO)
- Anahtar Kelimeler: Child, Hand surgery, Tendon entrapment, Thumb, Trigger finger disorder
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Recep Tayyip Erdoğan Üniversitesi Adresli: Evet
Özet
Objective: This study aimed to evaluate the efficacy and safety of pediatric trigger thumb release performed without tourniquet application. Methods: This retrospective study included 17 trigger thumb releases in 16 patients (11 female, 5 male) performed between October 2021 and December 2023. The mean patient age at surgery was 2.81 ± 0.75 years (range, 2-4). All procedures were conducted at a single center under deep sedation or laryngeal mask airway anesthesia using a transverse volar incision at the metacarpophalangeal joint to release the A1 pulley. Outcomes included postoperative range of motion, complications, reoperation, and parent-reported satisfaction. The mean follow-up was 38.87 ± 13.95 weeks. Results: Full interphalangeal joint range of motion was achieved in 94.12% of cases, with no major complications and no reoperations. Minor postoperative events occurred in 17.65 (3/17) of cases, including a superficial wound infection managed with oral antibiotics and early residual flexion deformity that resolved with physiotherapy within 2 months. Overall satisfaction was high, with most families reporting they were “very satisfied” with the surgical outcome. Conclusion: Tourniquet-free pediatric trigger thumb release appears to be a safe and effective option, achieving high rates of motion recovery and satisfaction without major complications. Level of Evidence: Level IV, Therapeutic study.